Search Results

How should the proper dose of a beta blocker be determined?

• Authors : Shand DG

Subjects: Dose-Response Relationship, Drug*; Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/*administration & dosage ; Coronary Disease/Coronary Disease/Coronary Disease/*drug therapy

• Source: Circulation [Circulation] 1983 Jun; Vol. 67 (6 Pt 2), pp. I86-8.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Print ISSN:

Record details

Blood Pressure, Hypertension, and the Risk of Aortic Dissection Incidence and Mortality: Results From the J-SCH Study, the UK Biobank Study, and a Meta-Analysis of Cohort Studies.

• Authors : Hibino, Makoto; Otaki, Yoichiro; Kobeissi, Elsa

• Source: Circulation; 3/1/2022, Vol. 145 Issue 9, p633-644, 12p

Record details

Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.

• Authors : Filippini T; Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy (T.F., M.M., M.V.).; Malavolti M

Subjects: Blood Pressure/Blood Pressure/Blood Pressure/*physiology ; Diet, Sodium-Restricted/Diet, Sodium-Restricted/Diet, Sodium-Restricted/*methods ; Hypertension/Hypertension/Hypertension/*etiology

• Source: Circulation [Circulation] 2021 Apr 20; Vol. 143 (16), pp. 1542-1567. Date of Electronic Publication: 2021 Feb 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.

• Authors : Zhang L; Cardiovascular Imaging Research Center, Division of Cardiology and Department of Radiology (L. Zhang, M.A., M.Z.O.H., R.M.A., A.R., T.G.N.), Massachusetts General Hospital, Boston.; Cardio-Oncology Program, Division of Cardiology, Department of Medicine (L. Zhang, D.A.Z., M.A., S.P.M., M.J.-O., T.G.N.), Massachusetts General Hospital, Boston.

Subjects: Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*administration & dosage ; Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*adverse effects ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*administration & dosage

• Source: Circulation [Circulation] 2020 Jun 16; Vol. 141 (24), pp. 2031-2034. Date of Electronic Publication: 2020 Jun 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.

• Authors : Ahmad Z; Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas (Z.A.).; Banerjee P

Subjects: Angiopoietin-like Proteins/Angiopoietin-like Proteins/Angiopoietin-like Proteins/*antagonists & inhibitors ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Hypertriglyceridemia/Hypertriglyceridemia/Hypertriglyceridemia/*drug therapy

• Source: Circulation [Circulation] 2019 Aug 06; Vol. 140 (6), pp. 470-486. Date of Electronic Publication: 2019 Jun 27.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.

• Authors : Ferdinand KC; Tulane University School of Medicine, New Orleans, LA (K.C.F.).; Balavoine F

Subjects: Enzyme Inhibitors/Enzyme Inhibitors/Enzyme Inhibitors/*therapeutic use ; Glutamyl Aminopeptidase/Glutamyl Aminopeptidase/Glutamyl Aminopeptidase/*antagonists & inhibitors ; Hypertension/Hypertension/Hypertension/*drug therapy

• Source: Circulation [Circulation] 2019 Jul 09; Vol. 140 (2), pp. 138-146. Date of Electronic Publication: 2019 Apr 24.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis.

• Authors : Mostofsky, Elizabeth; Chahal, Harpreet S.; Mukamal, Kenneth J.

• Source: Circulation; 3/8/2016, Vol. 133 Issue 10, p979-987, 9p

Record details

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.

• Authors : Everett BM; From the Divisions of Cardiovascular (B.M.E., P.L., P.M.R.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Preventive Medicine (B.M.E., R.J.G., P.M.R.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Subjects: Patient Admission*; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use

• Source: Circulation [Circulation] 2019 Mar 05; Vol. 139 (10), pp. 1289-1299.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial.

• Authors : Yin OQP; Daiichi-Sankyo Pharma Development, Basking Ridge, NJ (O.Q.P.Y., M.F.M., R.M., K.T.).; Antman EM

Subjects: Factor Xa/Factor Xa/Factor Xa/*metabolism ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*metabolism ; Pyridines/Pyridines/Pyridines/*metabolism

• Source: Circulation [Circulation] 2018 Oct 30; Vol. 138 (18), pp. 1963-1973.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease.

• Authors : Arya S; Division of Vascular Surgery and Endovascular Therapy, Department of Surgery (S.A., A.K., L.P.B.) .; Emory School of Medicine, and Department of Epidemiology, Rollins School of Public Health (S.A., Z.O.B.), Emory University, Atlanta, GA.

Subjects: Amputation, Surgical/Amputation, Surgical/Amputation, Surgical/*statistics & numerical data ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use ; Peripheral Arterial Disease/Peripheral Arterial Disease/Peripheral Arterial Disease/*drug therapy

• Source: Circulation [Circulation] 2018 Apr 03; Vol. 137 (14), pp. 1435-1446. Date of Electronic Publication: 2018 Jan 12.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details